4 Results for "

PDE1A1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PDE1A1" in MCE Product Catalog:

Cat. No.: HY-178478
CAS No.: 86009-41-8
Research Areas:  

Metabolic Disease

PDE1-IN-11 (Compound 5cc) is an orally active and highly selective PDE1A1 inhibitor. PDE1-IN-11 increases intracellular cAMP and cGMP levels, activating the PKA-CREB and NO-cGMP-PKG signaling pathways, promoting osteoblast differentiation and bone formation, while suppressing osteoclastogenesis and bone resorption. PDE1-IN-11 is promising for research of postmenopausal osteoporosis (PMO) and other bone metabolism disorders .
loading...
    loading...
Cat. No.: HY-120195
CAS No.: 1628342-10-8
Research Areas:  

Neurological Disease

PF-04677490 is a PDE1 inhibitor (IC50: 21 nM). PF-04677490 has IC50s of 21 nM, 83 nM, and 118 nM for PDE1B1, PDE1C, and PDE1A, respectively. PF-04677490 efficaciously inhibits cAMP- and cGMP-hydrolytic activity .
loading...
    loading...
Cat. No.: HY-100990
CAS No.: 78033-08-6
Research Areas:  

Neurological Disease

MMPX is a potent PDE1 inhibitor .
loading...
    loading...
Cat. No.: HY-147946
CAS No.: 3031349-98-8
PDE1-IN-4 (compound 2g) is a potent and selective PDE1 (phosphodiesterase-1) inhibitor, with IC50 values of 10, 145, and 354 nM for PDE1C, PDE1A, and PDE1B, respectively. PDE1-IN-4 inhibits myofibroblast differentiation of human lung fibroblasts induced by TGF-β1. PDE1-IN-4 shows anti-fibrosis effects through the regulation of cAMP (3′,5′-cyclic adenosine monophosphate) and cGMP (3′,5′-cyclic guanosine monophosphate). PDE1-IN-4 can be used for idiopathic pulmonary fibrosis (IPF) research .
loading...
    loading...